GlassScriptPhysician profile
Haydee Gonzalez Hidalgo
NPI 1912071481
$5,331.01
in general payments reported to CMS, 2019-2025
51 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,975 · 2020: $1,130 · 2021: $1,519 · 2022: $707.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $414.01 | 2019-2022 | |
| Glaxosmithkline, LLC. | $333.05 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $322.16 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $282.84 | 2019-2022 | |
| Seagen INC. | $257.38 | 2019-2022 | |
| Eisai INC. | $240.51 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $239.92 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $223.24 | 2019-2021 | |
| Amgen INC. | $213.23 | 2019-2022 | |
| Astellas Pharma US INC | $176.34 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.86 | 2019-2021 | |
| Karyopharm Therapeutics INC. | $142.97 | 2020-2021 | |
| Kite Pharma, INC. | $141.67 | 2021 | |
| Exelixis INC. | $140.25 | 2019 | |
| Janssen Biotech, INC. | $139.85 | 2019-2022 |
Show all 51 companies
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haydee Gonzalez Hidalgo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.